The National Institution for Health Innovation
The National Institute for Health Innovation (NIHI) is part of Auckland University, New Zealand's largest research-led academic institution. The NIHI is located on the University's new multi-million Tamaki Campus in Auckland and forms part of the University's School of Population Health.
Funded by governemt, multi-national pharmaceuticals and a number of other sources, the NIHI's research programmes focus on investigating the causes, prevention and treatment major health problems. Established in 1989, the CTRU co-ordinated clinical trials involving tens of thousands of people in Australasia, Asia and Europe.
The CTRU undertook pivotal trials in research projects involving up to $30 million investment in collaboration with health ministries and leading commercial pharmaceutical companies including Servier, Bristol Myers Squibb and Hoechst AG. In undertaking these projects, the CTRU has established an international reputation for high quality, large-scale trials and population-based cohort and case-control studies.
CTRU services and expertise are available to both commercial and public sector organisations worldwide The Clinical Trials Research Unit's services include:
As well as clinical trials, the NIHI performs specialist health research involving studies of the causes of disease. Research themes include investigator-initiated studies, collaboration with other research groups both nationally and internationally and focus on affordable, practicable interventions.
For further details on our programmes and services, please email enquiries@ctru.auckland.ac.nz to make initial contact.